Resource Centers
This site is a collaboration with the American Society for Clinical Pathology
- U.S. Urges Genetic Test Before Using Glaxo AIDS Drug
- Genetic Variants Associated With Risk of Statin-Induced Myopathy
- Pulmonary Arterial Hypertension More Severe in Carriers of BMPR2 Mutation
- Predictors of Severe Infantile Hyperbilirubinemia Identified
- Gestational Impaired Glucose Tolerance Linked to Postpartum Metabolic Dysfunction Outcomes
Pathology & Lab Medicine Journals
- Prognostic Role of Osteopontin Expression in Malignant Pleural Mesothelioma
- Reproducibility of Pretest Assessment in Suspected Pulmonary Embolism
- Propofol Attenuates Human Proximal Renal Tubular Epithelial Cell Injury Induced by Anoxia-Reoxygenation
- Effect of the Glycoprotein IIb/IIIa Inhibitor Tirofiban on Concentrations of Whole Blood Choline in Acute Coronary Syndromes
- Insidious Onset of Visual Disturbances in a Healthy 56-Year-Old Man
- Improving Laboratory Testing to Save Lives in Resource-Limited Settings, With a Particular Focus on HIV/AIDS: Humanitarian Efforts by the ASCP
Medscape Community Resources
POLL
PhRMA recently announced that its code of conduct now bans gifts such as pens and meals to prescribing clinicians from drug company sales reps. PhRMA says the updated code will reduce the perception of influence, but critics say the new code doesn't go far enough. What effect do you think this code will have on prescribers?
Pathology & Lab Medicine CME
- ASCO 2008: Breast Cancer
- Reversal of Proteinuric Renal Disease and the Emerging Role of Endothelin
- Barrett Esophagus: Prevalence of Central Adiposity, Metabolic Syndrome, and a Proinflammatory State
- ASCO 2008: Genitourinary Cancer
- ASCO 2008: Colorectal Cancer
Advisory Board
- Kathryn Foucar, MD, FASCP
- William A. Gardner, MD, FASCP
- Wayne W. Grody, MD, PhD, FASCP
- Denise Harmening, PhD, MT(ASCP), CLS(NCA)
- William R. Hart, MD, FASCP
- George D. Lundberg, MD, FASCP
- Robert W. McKenna, MD, FASCP
Editorial Director